Isomer Composition Assessment of Synthetic Phosphatidylethanol by Collision‐Induced and Ozone‐Induced Dissociation Mass Spectrometry
Drug Testing and Analysis · 2026
DOI: 10.1002/dta.70046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2026. Verfasst von Matthias Bantle und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Forensic Medicine Bern, Forensic Toxicology and Chemistry, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Glycerophospholipids. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Society for Traffic Medicine (DGVM), QUT, Adepa Lifesciences.
Abstract (Originalsprache)
The direct blood‐alcohol biomarker phosphatidylethanol (PEth), especially its most abundant analogue 1‐palmitoyl‐2‐oleoyl‐ sn ‐phosphatidylethanol (PEth 16:0/18:1) has gained increasing relevance in clinical and forensic applications for assessing alcohol consumption. Accurate quantification of PEth is essential to reliably differentiate between abstinence, moderate alcohol consumption and excessive alcohol intake. Measurement accuracy of PEth 16:0/18:1 by well‐established liquid chromatography–tandem mass spectrometry (LC‐MS/MS) approaches such as multiple reaction monitoring (MRM) can be confounded by the presence of the regioisomer 1‐oleoyl‐2‐palmitoyl‐ sn ‐phosphatidylethanol (PEth 18:1/16:0) in samples and synthetic reference standards. To address this measurement uncertainty, we conducted a new assessment of the isomeric composition of six currently available reference materials from four suppliers using collision‐induced dissociation/ozone‐induced dissociation (CID/OzID). Examination of these synthetic compounds found a high degree of regioisomeric purity of > 95%. Thus verified, the relative abundance of two key LC–MS/MS transitions were compared across a range of collision energies for both reference materials and an exemplary set of 10 dried blood spot case samples. These findings suggest a significantly wider range of natural isomer distributions spanning both higher and lower regiochemical composition (88.8%–98.85%) than the reference materials but within a range that would not significantly impact clinical classification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Forensic Medicine Bern, Forensic Toxicology and Chemistry, University of Bern, Bern, Switzerland.
- Department of Chemistry, Biochemistry and Pharmacy, University of Bern, Bern, Switzerland.
- Central Analytical Research Facility and School of Chemistry and Physics, Queensland University of Technology, Brisbane, Queensland, Australia.
- Molecular Horizons and School of Science, University of Wollongong, Wollongong, New South Wales, Australia.
- Institute for Clinical Chemistry, University Hospital and University of Zurich, Zurich, Switzerland.
ORCID-Profile: Matthias Bantle, Jackson O T Long, Samuel C Brydon, Reuben S E Young, Stephen J Blanksby, Wolfgang Weinmann, Marc Luginbühl
Förderung
- German Society for Traffic Medicine (DGVM)
- QUT
- Adepa Lifesciences
- Australian Research Council (ARC)
Zitieren
APA
Bantle, M., Long, J. O. T., Brydon, S. C., Young, R. S. E., Blanksby, S. J., Weinmann, W., & Luginbühl, M. (2026). Isomer Composition Assessment of Synthetic Phosphatidylethanol by Collision‐Induced and Ozone‐Induced Dissociation Mass Spectrometry. Drug Testing and Analysis. https://doi.org/10.1002/dta.70046
Vancouver
Bantle M, Long JOT, Brydon SC, Young RSE, Blanksby SJ, Weinmann W, et al. Isomer Composition Assessment of Synthetic Phosphatidylethanol by Collision‐Induced and Ozone‐Induced Dissociation Mass Spectrometry. Drug Testing and Analysis. 2026. doi:10.1002/dta.70046
BibTeX
@article{Bantle2026,
author = {Bantle, Matthias and Long, Jackson O T and Brydon, Samuel C and Young, Reuben S E and Blanksby, Stephen J and Weinmann, Wolfgang and Luginbühl, Marc},
title = {Isomer Composition Assessment of Synthetic Phosphatidylethanol by Collision‐Induced and Ozone‐Induced Dissociation Mass Spectrometry},
journal = {Drug Testing and Analysis},
year = {2026},
doi = {10.1002/dta.70046}
}
EUVIMED